Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
Cambridge, Mass.
Global medicine spend forecast to exceed $1.5 trillion by 2023
Global medicine spend forecast to exceed $1.5 trillion by 2023
A new report containing the latest predictions for the global pharmaceutical market has found that global spending on medicines is set to exceed $1.
Biogen beats estimates on multiple sclerosis drugs sales
Biogen beats estimates on multiple sclerosis drugs sales
(Reuters) - Biogen Inc beat analysts’ estimates for fourth-quarter profit and revenue on Tuesday, buoyed by higher sales of its top-selling multiple sclerosis drugs, and forecast full-year p...
Israeli cabinet approves law to allow medical cannabis exports
Israeli cabinet approves law to allow medical cannabis exports
JERUSALEM (Reuters) - Israel’s cabinet approved on Sunday a law to allow exports of medical cannabis in a move expected to boost state revenues and the agriculture sector, and which frustrat...
AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) - First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Previously Untreated Patien
AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) - First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Previously Untreated Patien
NORTH CHICAGO, Ill.
Alexion Announces Positive Top-Line Results From Phase 3 Study Of ULTOMIRIS™ (Ravulizumab-Cwvz) In Complement Inhibitor-Naïve Patients With Atypical Hemolytic Uremic Syndrome (AHUS)
Alexion Announces Positive Top-Line Results From Phase 3 Study Of ULTOMIRIS™ (Ravulizumab-Cwvz) In Complement Inhibitor-Naïve Patients With Atypical Hemolytic Uremic Syndrome (AHUS)
BOSTON--(BUSINESS WIRE) -- Jan.
Not-for-profit to offer 20 generic drugs in 2019 to alleviate shortages
Not-for-profit to offer 20 generic drugs in 2019 to alleviate shortages
(Reuters) - A new not-for-profit supplier of generic drugs formed by a consortium of hospitals systems said it expects this year to be able to provide about 20 products to alleviate shortages ...
Harvard researchers report positive trial results with artificial pancreas smartphone app
Harvard researchers report positive trial results with artificial pancreas smartphone app
The results of a new clinical trial have shown the safety and efficacy of the interoperable Artificial Pancreas System smartphone app (iAPS), which can interface wirelessly with leading contin...
Cystic fibrosis drug combo found safe and effective for 2- to 5-year-olds
Cystic fibrosis drug combo found safe and effective for 2- to 5-year-olds
An open label Phase 3 study conducted at Ann & Robert H.
Antimicrobial resistance: UK launches 5-year action plan and 20-year vision
Antimicrobial resistance: UK launches 5-year action plan and 20-year vision
The plans outline the UK's contribution to containing and controlling antimicrobial resistance (AMR) in health, animals, the environment and the food chain.
It Looks Like a Common Vaccine Is Unintentionally Helping Prevent Type 1 Diabetes
It Looks Like a Common Vaccine Is Unintentionally Helping Prevent Type 1 Diabetes
23 JAN 2019Type 1 diabetes has been on the rise worldwide, but in Australia, the problem appears to be turning around at last.
Chinese Scientists Have Cloned a Genetically Altered Primate For The First Time
Chinese Scientists Have Cloned a Genetically Altered Primate For The First Time
This time last year, the first primates cloned through a nucleus transfer technique made headlines around the world.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand